VHIO’s strong presence at ESMO 2026: advances in cancer prevention and personalised treatment
VHIO’s strong presence at ESMO 2026: advances in cancer prevention and personalised treatment VHIO
🎗️
Онкология
🎗️Лента новостей
🎗️
Онкология
BMS joins 3-year partnership to boost participation in cancer trials
BMS joins 3-year partnership to boost participation in cancer trials Fierce Biotech
Онкология
Врач-онколог назвал первые признаки рака молочной железы
Врач-онколог назвал первые признаки рака молочной железы ОНТ
Онкология
Could everyday prescribed medications be undermining thyroid cancer treatment?
Could everyday prescribed medications be undermining thyroid cancer treatment? Oncology Central
Онкология
Cancer: a surge in clinical trials – how China is challenging the world with smart drugs
Cancer: a surge in clinical trials – how China is challenging the world with smart drugs Il Sole 24 ORE
Онкология
GSK to nearly double cancer drugs in trials next year, WSJ reports
GSK to nearly double cancer drugs in trials next year, WSJ reports Yahoo Finance
Онкология
Cancer vaccines are finally here. How do we get them to patients?
Cancer vaccines are finally here. How do we get them to patients? STAT
Онкология
Привлечение вьетнамских женщин к более широким возможностям ранней диагностики рака.
Привлечение вьетнамских женщин к более широким возможностям ранней диагностики рака. Vietnam.vn
Онкология
Главное: GSK почти удвоит число клинических исследований в онкологии; позитивные данные фазы исследования
Главное: GSK почти удвоит число клинических исследований в онкологии; позитивные данные фазы исследования TradingView
Онкология
GSK to nearly double cancer drugs in trials next year, WSJ reports
GSK to nearly double cancer drugs in trials next year, WSJ reports KSL News
Онкология
Православным рассказали, кому молиться при лечении рака
Православным рассказали, кому молиться при лечении рака РИА «7 новостей»
Онкология
EIK1001 achieves 63.1% response rate in untreated stage 4 lung cancer
EIK1001 achieves 63.1% response rate in untreated stage 4 lung cancer The Clinical Trial Vanguard
Онкология
Citius Oncology Reports LYMPHIR Unit Sales, Vial Orders for Q4 2026
Citius Oncology Reports LYMPHIR Unit Sales, Vial Orders for Q4 2026 The Clinical Trial Vanguard
Онкология
Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment - News-Medical
Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment News-Medical
🎗️
Онкология
Онколог назвал инфекции, которые могут привести к раку
Онколог назвал инфекции, которые могут привести к раку www.championat.ru